Lotte N. Krogh
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.
Journal: BMC medical genomics
Published: October 09, 2024
Reclassification of Two MLH1 Variants of Uncertain Significance Utilizing Clinical and Functional Data.
Journal: Molecular genetics & genomic medicine
Published: June 17, 2024
Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.
Journal: Human genetics
Published: May 06, 2022
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.
Journal: Cancer research
Published: July 01, 2019
Exploring the hereditary background of renal cancer in Denmark.
Journal: PloS one
Published: August 29, 2018
Is MED13L-related intellectual disability a recognizable syndrome?
Journal: European journal of medical genetics
Published: February 24, 2018
Risks and Recommendations in Prenatally Detected De Novo Balanced Chromosomal Rearrangements from Assessment of Long-Term Outcomes.
Journal: American journal of human genetics
Published: February 02, 2018
Novel Somatic RET Mutation Questioning the Causality of the RET I852M Germline Sequence Variant in Multiple Endocrine Neoplasia 2A.
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 06, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 28, 2017
Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T).
Journal: Current genomics
Published: April 10, 2016
No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.
Journal: Familial cancer
Published: March 09, 2016
Last Updated: 09/26/2026